Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.

We measured the binding of IGF-I and IGF-II to recombinant human N-terminal [residues 1-97; recombinant human IGF-binding protein-3(1-97) (rhIGFBP-3(1-97))] and C-terminal (residues 98-264; rhIGFBP-3(98-264)) IGFBP-3 fragments and compared it with IGF binding to intact IGFBP-3 using biosensor analysis. Experiments were carried out in different configurations, either with binding protein or fragment immobilized or with IGF immobilized. These experiments showed that IGF-I and IGF-II bind to IGFBP-3 with affinities of 4-5 x 10(9) M(-1) and similar binding kinetics. The affinities of both rhIGFBP-3(1-97) and rhIGFBP-3(98-264) for IGF proteins were approximately 3 orders of magnitude less than that of full-length IGFBP-3. These results further support the concept that high affinity binding of IGF to IGF-binding proteins results from a two-site interaction of IGF with both the N- and C-terminal regions of the binding protein. Binding of insulin to IGFBP-3 and its N- and C-terminal fragments and of IGF-I and IGF-II to the structurally related proteins mac25 and connective tissue growth factor was also investigated. Weak insulin binding to full-length IGFBP-3 could be demonstrated in a few experiments, but we found that binding of IGF-I, IGF-II, and insulin to mac25 or connective tissue growth factor was below the detection limit of the biosensor instrument.

[1]  B. Ursø,et al.  Mechanism of Insulin and IGF‐I , 1995 .

[2]  C. Renner,et al.  Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions , 1998, The EMBO journal.

[3]  D. Clemmons,et al.  Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4 , 1995, The Journal of Biological Chemistry.

[4]  G. Devi,et al.  Differential Effects of Insulin-Like Growth Factor (IGF)-Binding Protein-3 and Its Proteolytic Fragments on Ligand Binding, Cell Surface Association, and IGF-I Receptor Signaling* * This research was supported by US Army Grants DAMD17-991-9522 (to G.R.D.) and DAMD17-96-1-6204 and DAMD17-96-1-7204 (t , 2000, Endocrinology.

[5]  P. Schuck,et al.  Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. , 1997, Annual review of biophysics and biomolecular structure.

[6]  M. Binoux,et al.  Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. , 1990, The Journal of clinical endocrinology and metabolism.

[7]  E. Spencer,et al.  A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. , 1995, Progress in growth factor research.

[8]  E. Wilson,et al.  Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Schuck,et al.  Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.

[10]  R. Rosenfeld,et al.  Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.

[11]  R. Gill,et al.  Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3* , 1996, The Journal of Biological Chemistry.

[12]  M. Hämäläinen,et al.  Biosensor analysis of drug-target interactions: direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors. , 2000, Analytical biochemistry.

[13]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[14]  M. Binoux,et al.  Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  A. Minton,et al.  Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. , 1996, Analytical biochemistry.

[16]  D. Clemmons,et al.  Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. , 1992, Endocrinology.

[17]  E. Wilson,et al.  Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. , 1998, The Journal of clinical endocrinology and metabolism.

[18]  E. Wilson,et al.  Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. , 1999, The Journal of clinical endocrinology and metabolism.

[19]  R. Rosenfeld,et al.  IGF-Independent Actions of the IGF Binding Proteins , 1999 .

[20]  F. Masiarz,et al.  Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. , 1992, The Journal of biological chemistry.

[21]  R. Baxter,et al.  Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. , 1999, The Journal of endocrinology.

[22]  R. Baxter,et al.  Insulin-like growth factor-binding protein from human plasma. Purification and characterization. , 1986, The Journal of biological chemistry.

[23]  J. Fowlkes,et al.  A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by Western ligand blotting. , 1996, Endocrinology.

[24]  M. Rechler,et al.  Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. , 1993, The Journal of biological chemistry.

[25]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[26]  R. Baxter,et al.  Structural Determinants of Ligand and Cell Surface Binding of Insulin-like Growth Factor-binding Protein-3* , 1998, The Journal of Biological Chemistry.

[27]  A. López-Bermejo,et al.  The insulin-like growth factor binding protein superfamily: new perspectives. , 1999, Pediatrics.

[28]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.

[29]  Y. Yamanaka,et al.  Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  R. Rosenfeld,et al.  Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. , 1993, Endocrinology.

[31]  C. Fong,et al.  Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. , 1999, Biochimica et biophysica acta.

[32]  L. Maile,et al.  Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[33]  R. Rosenfeld,et al.  Synthesis of IGFBP-3 fragments in a baculovirus system and characterization of monoclonal anti-IGFBP-3 antibodies. , 1997, The Journal of clinical endocrinology and metabolism.

[34]  P. Schuck,et al.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport. , 1996, Biophysical journal.

[35]  R. Baxter,et al.  Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I. , 1991, The Journal of clinical endocrinology and metabolism.

[36]  M. Binoux,et al.  A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. , 1996, Endocrinology.

[37]  M. Binoux,et al.  Biological Actions of Proteolytic Fragments of the IGF Binding Proteins , 1999 .

[38]  R W Glaser,et al.  Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics. , 1993, Analytical biochemistry.

[39]  L. Giudice,et al.  Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. , 1990, The Journal of clinical endocrinology and metabolism.

[40]  E. Wilson,et al.  Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins* , 1997, The Journal of Biological Chemistry.

[41]  S. Nagalla,et al.  Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7 , 1996, The Journal of Biological Chemistry.

[42]  J. Wallace,et al.  Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain* , 1998, The Journal of Biological Chemistry.

[43]  R. Baxter,et al.  Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3. , 2001, The Journal of endocrinology.

[44]  P. Hogarth,et al.  Differential dissociation kinetics explain the binding preference of insulin‐like growth factor binding protein‐6 for insulin‐like growth factor‐II over insulin‐like growth factor‐I , 1999, FEBS letters.

[45]  S. Loefas,et al.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. , 1991, Analytical biochemistry.

[46]  D G Myszka,et al.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Methods in enzymology.

[47]  L. Schäffer.  A model for insulin binding to the insulin receptor. , 1994, European journal of biochemistry.